Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization.

作者: Chun Chao , Christine Velicer , Jeff M. Slezak , Steven J. Jacobsen

DOI: 10.4065/84.10.864

关键词:

摘要: OBJECTIVE To examine the rate and correlates of completion quadrivalent human papillomavirus vaccine (HPV4) 3-dose regimen because nonadherence to may adversely affect efficacy. PARTICIPANTS AND METHODS Female members Kaiser Permanente Southern California who were 9 26 years old, received first dose HPV4 between October 2006 March 2007, maintained health plan membership 12 months afterward identified followed up for completion. We examined following: (1) demographics/socioeconomic status, (2) primary care physician characteristics, (3) historical service utilization, (4) women's health-related conditions, (5) selected immune-related conditions their association with in 2 age groups: 17 18 years. Multivariable log-binomial regression was used directly estimate relative risk (RR). RESULTS Of 34,193 females initiated HPV4, 41.9% 9- 17-year-old group 47.1% 18- 26-year-old group. Black race (RR, 0.70; 95% confidence interval [CI], 0.64-0.77) lower neighborhood education level associated However, those covered by state-subsidized program Medi-Cal more likely complete 1.14; CI, 1.07-1.22). Historical hospitalizations emergency department visits 0.92; 0.87-0.96; RR, 0.96; 0.94-0.98 per visit, respectively) having a pediatrician also predictors noncompletion. A history sexually transmitted diseases, abnormal Papanicolaou test results, (eg, asthma/infections) not CONCLUSION These findings suggest that factors such as or socioeconomic status should be considered when vaccination programs are being designed evaluated.

参考文章(12)
L L Villa, R L R Costa, C A Petta, R P Andrade, J Paavonen, O-E Iversen, S-E Olsson, J Høye, M Steinwall, G Riis-Johannessen, A Andersson-Ellstrom, K Elfgren, G von Krogh, M Lehtinen, C Malm, G M Tamms, K Giacoletti, L Lupinacci, R Railkar, F J Taddeo, J Bryan, M T Esser, H L Sings, A J Saah, E Barr, High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up British Journal of Cancer. ,vol. 95, pp. 1459- 1466 ,(2006) , 10.1038/SJ.BJC.6603469
Catarina I Kiefe, Ellen Funkhouser, Dr Ph, Mona N Fouad, Daniel S May, Chronic disease as a barrier to breast and cervical cancer screening. Journal of General Internal Medicine. ,vol. 13, pp. 357- 365 ,(1998) , 10.1046/J.1525-1497.1998.00115.X
Wansu Chen, Diana B Petitti, Shelley Enger, Limitations and potential uses of census-based data on ethnicity in a diverse community. Annals of Epidemiology. ,vol. 14, pp. 339- 345 ,(2004) , 10.1016/J.ANNEPIDEM.2003.07.002
Jean A. McDougall, Margaret M. Madeleine, Janet R. Daling, Christopher I. Li, Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992−2003 Cancer Causes & Control. ,vol. 18, pp. 1175- 1186 ,(2007) , 10.1007/S10552-007-9056-Y
J.M. Riedesel, S.L. Rosenthal, G.D. Zimet, D.I. Bernstein, B. Huang, D. Lan, J.A. Kahn, Attitudes about Human Papillomavirus Vaccine among Family Physicians Journal of Pediatric and Adolescent Gynecology. ,vol. 18, pp. 391- 398 ,(2005) , 10.1016/J.JPAG.2005.09.004
Tiepu Liu, Xingqiu Wang, John W. Waterbor, Heidi L. Weiss, Seng-Jaw Soong, Relationships Between Socioeconomic Status and Race-Specific Cervical Cancer Incidence in the United States, 1973-1992 Journal of Health Care for the Poor and Underserved. ,vol. 9, pp. 420- 432 ,(1998) , 10.1353/HPU.2010.0482
John Sellors, Max Chernesky, Mirza Zimic-Vincetic, Laura Pickard, James B. Mahony, Penny Nelligan, Karen Jackson, Understanding and enhancing compliance with the second dose of hepatitis B vaccine: a cohort analysis and a randomized controlled trial. Canadian Medical Association Journal. ,vol. 157, pp. 143- 148 ,(1997)
Luisa L Villa, Ronaldo LR Costa, Carlos A Petta, Rosires P Andrade, Kevin A Ault, Anna R Giuliano, Cosette M Wheeler, Laura A Koutsky, Christian Malm, Matti Lehtinen, Finn Egil Skjeldestad, Sven-Eric Olsson, Margareta Steinwall, Darron R Brown, Robert J Kurman, Brigitte M Ronnett, Mark H Stoler, Alex Ferenczy, Diane M Harper, Gretchen M Tamms, Jimmy Yu, Lisa Lupinacci, Radha Railkar, Frank J Taddeo, Kathrin U Jansen, Mark T Esser, Heather L Sings, Alfred J Saah, Eliav Barr, None, Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncology. ,vol. 6, pp. 271- 278 ,(2005) , 10.1016/S1470-2045(05)70101-7
US Preventive Services Task Force, None, Screening for cervical cancer: recommendations and rationale. American Journal of Nursing. ,vol. 103, pp. 101- ,(2003)